GEMMABio
Business Services · Pennsylvania, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
3025 John F Kennedy Blvd Ste 220, Philad...Phone Number
(445) 201-3569Website
www.gemmabiotx.comRevenue
$16.3 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
2
1
1
1
2
1
About GEMMABio
GEMMABio is a therapeutics company focused on speeding the research of and global access to life-changing advanced therapies for those living with rare diseases. The company will provide research and product development functions to bring gene therapy discoveries from the bench to the bedside faster and affordably. GEMMABio is led by gene therapy industry pioneer Jim Wilson and his team of experts, who previously conducted their work in academia. Wilson is also the Chairperson of Franklin Biolabs, a Contract Research Organization. The collective goal of the two affiliated companies is to translate innovative scientific work into clinical trials, to then commercialize and distribute the new therapies around the world to patients who need them most.Explore more
GEMMABio Org Chart
Get the full picture
Sign in to uncover key details.
HB
Director, Neurology
JT
Director, Clinical Operations
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is GEMMABio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if GEMMABio is spiking on competitors!
Earning: See what the market has to say on GEMMABio recently announced quarterly report
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once GEMMABio has new funding data
Check if GEMMABio has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when GEMMABio launches new products
Click to see if GEMMABio had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at GEMMABio
Competitive Alert! Recent activity has been detected by your competitor Masked Content
GEMMABio, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined GEMMABio as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
GEMMABio is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
GEMMABio is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about GEMMABio.
GEMMABio financials insights
Gather financial insights about GEMMABio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Angel/Seed
$34M
GEMMABio Tech Stack
A closer look at the technologies used by GEMMABio
See more technologies
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Open Position
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Product Development, Product Management, Governmental Affairs & Regulation, Medical Research, Pharmaceuticals, Clinical Operations, Regulations
GEMMABio News & Media
Gene Therapy Pioneer Jim Wilson Comments on Solid Biosciences's Announcement of FDA IND Clearance for Friedreich's Ataxia Treatment
PHILADELPHIA, Jan. 8, 2025 /PRNewswire/ -- Today, Dr. Jim Wilson, President and CEO of GEMMA Biotherapeutics ("GEMMABio") commented on Solid Bioscience's announcement of clearance by the Food and Drug Administration for its Investigational New Drug (IND) to treat Friedreich's ataxia (FA):...GEMMABio Appoints Dr. May Orfali as Chief Medical Officer
Experienced medical executive brings expansive knowledge in clinical development and medical affairs PHILADELPHIA, Jan. 8, 2025 /PRNewswire/ -- GEMMA Biotherapeutics ("GEMMABio") – a new therapeutics company founded by gene therapy pioneer Dr. Jim Wilson – today announced that it has...GEMMABio Raises $34M in Seed Funding
Gemma Biotherapeutics, a Philadelphia, PA-based therapeutics company, closed a $34m seed funding. The round was co-led by Double Point Ventures, Bioluminescence Ventures and Earlybird Venture Capital, with additional backing from Savanne Life Sciences. The company intends to use the funds to accelerate operational expansion and innovative gene therapy programs. Founded by Dr. Jim Wilson, GEMMABio is at the forefront […] The post GEMMABio Raises $34M in Seed Funding appeared first on FinSMEs.
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding GEMMABio
Sign Up For FreeTo access detailed company insights
GEMMABio is a therapeutics company focused on speeding the research of and global access to life-changing advanced therapies for those living with rare diseases. The company will provide research and product development functions to bring gene therapy discoveries from the bench to the bedside faster and affordably. GEMMABio is led by gene therapy i... Read More
